[1] |
Walters EH, Shukla SD. Silicosis: pathogenesis and utility of animal models of disease. Allergy, 2021; 76, 3241−2. |
[2] |
Hoy RF, Baird T, Hammerschlag G, et al. Artificial stone-associated silicosis: a rapidly emerging occupational lung disease. Occup Environ Med, 2018; 75, 3−5. |
[3] |
Gołębiowski T, Kuźniar J, Porażko T, et al. Multisystem amyloidosis in a coal miner with silicosis: is exposure to silica dust a cause of amyloid deposition? Int J Environ Res Public Health, 2022; 19, 2297. |
[4] |
Koskinen H. Symptoms and clinical findings in patients with silicosis. Scand J Work Environ Health, 1985; 11, 101−6. |
[5] |
Liu X, Jiang QT, Wu PH, et al. Global incidence, prevalence and disease burden of silicosis: 30 years' overview and forecasted trends. BMC Public Health, 2023; 23, 1366. |
[6] |
Jandová R, Widimský J, Eisler L, et al. Long-term prognosis of pulmonary hypertension in silicosis. Cor Vasa, 1980; 22, 221−37. |
[7] |
Milovanović A, Nowak D, Milovanović A, et al. Silicotuberculosis and silicosis as occupational diseases: report of two cases. Srp Arh Celok Lek, 2011; 139, 536−9. |
[8] |
Vranic S, Shimada Y, Ichihara S, et al. Toxicological evaluation of SiO2 nanoparticles by zebrafish embryo toxicity test. Int J Mol Sci, 2019; 20, 882. |
[9] |
Maser E, Schulz M, Sauer UG, et al. In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials. Mutat Res/Genet Toxicol Environ Mutagen, 2015; 794, 57−74. |
[10] |
Pellen-Mussi P, Tricot-Doleux S, Neaime C, et al. Evaluation of functional SiO2 nanoparticles toxicity by a 3D culture model. J Nanosci Nanotechnol, 2018; 18, 3148−57. |
[11] |
Zhang FF, You XY, Zhu TT, et al. Silica nanoparticles enhance germ cell apoptosis by inducing reactive oxygen species (ROS) formation in Caenorhabditis elegans. J Toxicol Sci, 2020; 45, 117−29. |
[12] |
Liu W, Hu T, Zhou L, et al. Nrf2 protects against oxidative stress induced by SiO2 nanoparticles. Nanomedicine, 2017; 12, 2303−18. |
[13] |
Nho R. Pathological effects of nano-sized particles on the respiratory system. Nanomed: Nanotechnol, Biol Med, 2020; 29, 102242. |
[14] |
Guerrero-Beltrán CE, Bernal-Ramírez J, Lozano O, et al. Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol, 2017; 312, H645−61. |
[15] |
Otsuki T, Hayashi H, Nishimura Y, et al. Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol, 2011; 24, 11S−6S. |
[16] |
Delgado-García D, Miranda-Astorga P, Delgado-Cano A, et al. Workers with suspected diagnosis of silicosis: a case study of sarcoidosis versus siderosis. Healthcare, 2023; 11, 1782. |
[17] |
Liu TY, Bao R, Wang QS, et al. SiO2-induced ferroptosis in macrophages promotes the development of pulmonary fibrosis in silicosis models. Toxicol Res, 2022; 11, 42−51. |
[18] |
Tang DL, Kroemer G. Ferroptosis. Curr Biol, 2020; 30, R1292−7. |
[19] |
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell, 2014; 156, 317−31. |
[20] |
Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal, 2018; 29, 1756−73. |
[21] |
Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 2019; 23, 101107. |
[22] |
Ma J, Wang JQ, Ma CJ, et al. Wnt5a/Ca2+ signaling regulates silica-induced ferroptosis in mouse macrophages by altering ER stress-mediated redox balance. Toxicology, 2023; 490, 153514. |
[23] |
Li N, Chang MY, Zhou Q, et al. Activation of AMPK signalling by Metformin: implication an important molecular mechanism for protecting against mice silicosis via inhibited endothelial cell-to-mesenchymal transition by regulating oxidative stress and apoptosis. Int Immunopharmacol, 2023; 120, 110321. |
[24] |
Liu PF, Feng YT, Li HW, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett, 2020; 25, 10. |
[25] |
Teixeira KC, Soares FS, Rocha LGC, et al. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther, 2008; 21, 309−16. |
[26] |
Ali MK, Kim RY, Brown AC, et al. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease. J Pathol, 2020; 251, 49−62. |
[27] |
Li N, Wang W, Zhou H, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med, 2020; 160, 303−18. |
[28] |
Yazaki K, Yoshida K, Hyodo K, et al. Pulmonary hypertension due to silicosis and right upper pulmonary artery occlusion with bronchial anthracofibrosis. Respir Med Case Rep, 2021; 34, 101522. |
[29] |
Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation, 2006; 114, 1883−91. |
[30] |
Gellissen J, Pattloch D, Möhner M. Effects of occupational exposure to respirable quartz dust on acute myocardial infarction. Occup Environ Med, 2019; 76, 370−5. |
[31] |
Chen Z, Meng H, Xing GM, et al. Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: nanotoxicity has susceptible population. Environ Sci Technol, 2008; 42, 8985−92. |
[32] |
Libby P, Ridker PM, Hansson GK, et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol, 2009; 54, 2129−38. |
[33] |
Andresdottir MB, Sigfusson N, Sigvaldason H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik study. Am J Epidemiol, 2003; 158, 844−51. |
[34] |
Nemmar A, Yuvaraju P, Beegam S, et al. Oxidative stress, inflammation, and DNA damage in multiple organs of mice acutely exposed to amorphous silica nanoparticles. Int J Nanomed, 2016; 11, 919−28. |
[35] |
Boovarahan SR, Kurian GA. Mitochondrial dysfunction: a key player in the pathogenesis of cardiovascular diseases linked to air pollution. Rev Environ Health, 2018; 33, 111−22. |
[36] |
Lozano O, Silva-Platas C, Chapoy-Villanueva H, et al. Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytes. Part Fibre Toxicol, 2020; 17, 15. |
[37] |
Falcon-Rodriguez CI, Osornio-Vargas AR, Sada-Ovalle I, et al. Aeroparticles, composition, and lung diseases. Front Immunol, 2016; 7, 3. |
[38] |
Fan CJ, Graff P, Vihlborg P, et al. Silica exposure increases the risk of stroke but not myocardial infarction-A retrospective cohort study. PLoS One, 2018; 13, e0192840. |
[39] |
Jiang XJ, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 2021; 22, 266−82. |
[40] |
Zhao WK, Zhou Y, Xu TT, et al. Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury. Oxid Med Cell Longev, 2021; 2021, 9929687. |
[41] |
Li T, Tan Y, Ouyang S, et al. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene, 2022; 808, 145968. |
[42] |
Sumneang N, Siri-Angkul N, Kumfu S, et al. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes. Arch Biochem Biophys, 2020; 680, 108241. |
[43] |
Wang H, An P, Xie EJ, et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology, 2017; 66, 449−65. |
[44] |
Sun CF, Peng F, Li JF, et al. Ferroptosis-specific inhibitor ferrostatin-1 relieves H2O2-induced redox imbalance in primary cardiomyocytes through the Nrf2/ARE pathway. Dis Markers, 2022; 2022, 4539932. |
[45] |
Chen H, Zhu J, Le YF, et al. Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway. Phytomedicine, 2022; 99, 153964. |
[46] |
Zhang W, Qian SH, Tang B, et al. Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation. J Cell Mol Med, 2023; 27, 3075−3089. |
[47] |
Anandhan A, Dodson M, Schmidlin CJ, et al. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol, 2020; 27, 436−47. |
[48] |
Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell, 2019; 35, 830−49. |
[49] |
Chang LC, Chiang SK, Chen SE, et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett, 2018; 416, 124−37. |
[50] |
Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal, 2018; 29, 1727−45. |
[51] |
Ooi BK, Goh BH, Yap WH. Oxidative stress in cardiovascular diseases: involvement of Nrf2 antioxidant redox signaling in macrophage foam cells formation. Int J Mol Sci, 2017; 18, 2336. |
[52] |
Zelko IN, Zhu JX, Ritzenthaler JD, et al. Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica. Respir Res, 2016; 17, 160. |